CPSA Brasil 2014

Emerging Models for Drug Development and the Clinical Laboratory: Innovative Technologies and Future Applications

Final Program Agenda

Updated July 23, 2014

Monday 28 July



Pre-Conference Workshops

8:30 am - 12:00 pm

Highly Successful Strategies for LC/MS Quantitation
Rick King, PharmaCadence and Daniel Lebre, CEMSA

2:00 pm - 5:00 pm

Analytical Strategies for Degradation Products Studies
Michael Murgu, Waters Corporation

Pharmaceutical Sciences
Lauro Moretto, Sindusfarma and Mike Lee, Milestone Development Services



9:00 am - 12:00 pm

Recent Advances in Transporters and Human PK - Session 1
Cristiano Guimaraes, Aché Laboratórios Farmacêuticos S. A. and Ayman El-Kattan, Pfizer

1:30 pm - 4:00 pm

Recent Advances in Transporters and Human PK - Session 1
Cristiano Guimaraes, Aché Laboratórios Farmacêuticos S. A. and Ayman El-Kattan, Pfizer

Tuesday 29 July

7:30 am - 8:30 am

Registration & Continental Breakfast

8:30 am - 9:00 am

Welcome & Opening Remarks

Mike Lee

Welcome
Mike S. Lee
Milestone Development Services

Daniel Lebre

Format, Objectives, Opening Remarks
Daniel Lebre
CEMSA Laboratories

9:00 am - 10:00 am
10:00 am - 10:30 am

Break/Roundtables

10:30 am - 12:00 pm

Challenges and Opportunities Faced in BA/BE Studies
Chair: Gary Impey, AB Sciex

  • Future Trends of Bioequivalence: An Anvisa Perspective
  • Gustavo Santos, ANVISA

  • BE/BA in Brazil: Past, Present and Future Perspectives
  • Katia Pastre, MAGABI (Eurofarma)

  • Global Bioanalysis Consortium Update and Related Topics
  • Maria Francesca Riccio, CAEP

    12:15 pm - 1:15 pm

    Sponsored Lunch & Roundtable Event
    Sponsored by AB Sciex

    AB Sciex

    1:30 pm - 3:00 pm

    Biomarker and Clinical Analysis
    Chair: Dulce Casarini, Universidade Federal de São Paulo

  • Companion Diagnostics and Personalized Medicine in LatAm
  • Roberto Araújo, Reprogenetics Brazil

  • Proteomics for Revealing Biomarkers and Understanding Clinical Depression
  • Daniel Martins-de-Souza, University of Campinas

  • Monitoring of Biological Processes and Identification of Biomarkers in Renal Transplantation
  • Juliana Dinéia Perez, Universidade Federal de São Paulo

    3:00 pm - 3:30 pm

    Break/Roundtables

    3:30 pm - 5:00 pm

    A Perspective of Pharmaceutical Development in Brazil
    Chairs: Rafael Barrientos, Eurofarma and Lauro Moretto, Sindusfarma

    A Regulatory Perspective: RDC58/13-Degradation Products
    Sâmia Rocha de Oliveira Melo, ANVISA

    An Industry Perspective: Overview on the Pharmaceutical Development in Brazil
    Gabriel Lima Barros Araujo, University of Sao Paulo

    A Third Party Perspective: Challenges on the Analytical Development
    Luiz Silva, US Pharmacopeia

    Wednesday 30 July

    7:30 am - 8:30 am

    Registration & Continental Breakfast

    8:30 am - 9:30 am

    Plenary Lecture

    9:30 am - 10:00 am

    Break/Roundtables

    10:00 am - 11:30 am

    Protein Quantitation
    Chair, Nalini Sadagopan, Agilent Technologies

  • Protein Quantitation by Mass Spectrometry
  • Nalini Sadagopan, Agilent Technologies

  • Analytical Systems for Biology
  • Rick King, PharmaCadence Analytical Services

  • Biomarkers of Diabetes in Plasma of Non-Obese Diabetic Mice
  • Juliana Almada Colucci, Universidade Federal de São Paulo

    11:45 am - 12:45 pm

    Sponsored Lunch & Roundtable Event
    Sponsored by Agilent Technologies

    Agilent Technologies

  • A View on Analytical Capabilities for Pharmaceutical Development
  • Rafael Barrientos, Eurofarma

  • Novel Chromatographic Solutions for Pharmaceutical Development
  • Nalini Sadagopan, Agilent Technologies

    1:00 pm - 2:30 pm

    Drug Discovery and DMPK
    Chair: Marcos Eberlin, University of Campinas

  • Phenotypic Screening for Drug Discovery for Neglected Diseases and Its Advantages in Lead Optimization Studies
  • Lucio Freitas-Junior, National Laboratory of Biosciences (LNBio)

  • ABC of Handling New Chemical Entities with Active Hepatic Uptake as a Rate Determining Step: Industrial Perspective
  • Ayman El-Kattan, Pfizer

  • Use of LC-MS/MS in the Pre-Clinical and Clinical Development of Dapaconazole, a Novel Antifungal Agent
  • Gilberto De Nucci, Universidade de São Paulo

    2:30 pm - 2:45 pm

    Wrap Up & Adjourn
    Daniel Lebre, CEMSA and Mike Lee, Milestone Development Services